Topic

Articles

Editors' picks of pharmaceutical science and technology innovations.

In the Spotlight June 2010

Sean Milmo is a freelance writer based in Essex, UK.

Europe moves to place excipient GMP and GDP standards on the same level as active pharmaceutical ingredients.

Report from Europe

Too much or too little control can actually lead to the same result.

Everybody's Got Problems

Gary Walz is Senior Product Manager at Thermo Fisher Scientific.

A laboratory information system (LIMS) is a key tool in facilitating communication between a pharmaceutical company and its outsourcing partners; however, most LIMS require extensive customisation before they can be used in the pharmaceutical industry.

Data sharing more efficient with purpose-built LIMS

Bayer to Open San Francisco Innovation Hub; Lonza Bioscience Names COO; And More.

Week of May 24, 2010: Company and People Notes: Bayer to Open San Francisco Innovation Hub; Lonza Bioscience Names COO; And More.

Lonza Acquires MODA; Sigma-Aldrich Exec to Retire; And More.

Week of May 17, 2010: Company and People Notes: Lonza Acquires MODA; Sigma-Aldrich Exec to Retire; And More.

Life-sciences companies spend proportionally more resources on information technology and get less in return on their investment than companies in other industries. The poor return on investment partly results from regulatory costs that are unique to the pharmaceutical industry, but also stems from a failure to manage data strategically.

Using Strategic Data Management to Boost Efficiency

Online process monitoring could help companies achieve the dual goals of ensuring high end-product quality and satisfying regulatory demands.

Online Process Monitoring Can Satisfy Patients and Regulators

Week Of May 10, 2010: Company And People Notes: Ariad and Merck Restructure Collaboration; Genzyme Changes Leadership; and More

FDA Approves AstraZeneca's and Pozen's Vimovo; Merck Announces Management Changes; And More.

Data and Artificial Intelligence